ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cartitude-4', '3 car,(-23 care)', 'multiplemyeloma', 'cartitude', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'janssen']
at janssen, we re striving to transform the treatment of #multiplemyeloma through personalized treatments. learn more about our phase 3 cartitude-4 trial at #asco23: 
At Janssen, we never stop working toward a future where disease is a thing of the past. Channel run by Janssen Global Services LLC, NJ, USA.